Related Experiment Video
Updated: May 5, 2026

07:29
Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
11.4K
Intralesional interferon alfa-2b for refractory, recurrent squamous cell carcinoma of the face
Allison Hanlon1, June Kim, David J Leffell
1Department of Dermatology, Section of Cutaneous Oncology and Dermatologic Surgery, Yale University School of Medicine, New Haven, Connecticut.
Journal of the American Academy of Dermatology
|November 19, 2013
Abstract
No abstract available in PubMed .
More Related Videos
Related Concept Videos
Treatment Resistant Cancers
2.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
2.7K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K

